Table 1.
Patient characteristics
| Case | Age | Sex | TNM | Primary site | Smoking | HT | DM | HL | Chemotherapy | RT dose |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 75 | Male | T1bN0M0 | Lt | + | - | - | - | CDGP + 5-FU | 60 Gy/30 fr |
| 2 | 82 | Male | T1bN0M0 | Lt | + | + | - | - | CDGP + 5-FU | 60 Gy/30 fr |
| 3 | 82 | Male | T1bN0M0 | Mt | + | - | - | + | None | 66 Gy/33 fr |
| 4 | 73 | Male | T3N0M0 | Mt | + | - | - | - | CDDP + 5-FU | 60 Gy/30 fr |
| 5 | 73 | Male | T1bN0M0 | Lt | + | - | - | - | CDDP + 5-FU | 60 Gy/30 fr |
Abbreviations: HT hypertension, DM diabetes, HL hyperlipidemia, RT radiation, Lt lower thoracic esophagus, Mt middle thoracic esophagus, CDGP Nedaplatin, CDDP cisplatin, 5-FU 5-fluorouracil.